Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Fedro A. Peccatori,Hatem A. Azim,Roberto Orecchia,Harald J. Hoekstra,Nicholas Pavlidis,V. Kesic,George Pentheroudakis +6 more
Reads0
Chats0
TLDR
The aim of this work is to provide a systematic review and meta-analysis of the literature on canine coronavirus infection and its role in infertility and procreation that has been reported on in previous studies and is concerned with the well-being of newborns.About:
This article is published in Annals of Oncology.The article was published on 2013-10-01 and is currently open access. It has received 598 citations till now.read more
Citations
More filters
Book ChapterDOI
Preservation of Fertility in the Cancer Patient
Duhem Caroline,Fernand Ries +1 more
TL;DR: Preservation of fertility is a key determinant of long-term quality of life of adolescents and young adults treated for curable forms of cancer, especially in young women.
Book ChapterDOI
Breast Cancer in Special Groups: Breast Cancer in Pregnancy
TL;DR: The present chapter aims to review the management of women with BCP, focusing on diagnosis and staging, local and systemic treatments, obstetric care and long-term follow-up of children with prenatal exposure to anticancer treatments.
Book ChapterDOI
You Have a New Super Power: Ethics of oocyte Cryopreservation
TL;DR: This chapter will be an ethical analysis on challenging situations surrounding oocyte cryopreservation treatment in young healthy women and address ethical uncertainties presenting case studies, ethical questions and terms, existing arguments in favor and against oocytes cryop Reservation; and examine the individual patient’s beliefs, perception and opinions.
Journal ArticleDOI
Treatment of Pregnancy-Associated Breast Cancer
TL;DR: Pregnancy-associated breast cancer (PABC) is the most common malignancy diagnosed in women of childbearing age and is increasing in frequency as the average age of pregnancy rises as mentioned in this paper.
References
More filters
Journal ArticleDOI
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Joseph A. Sparano,Joseph A. Sparano,Molin Wang,Silvana Martino,Vicky Jones,Edith A. Perez,Tom Saphner,Antonio C. Wolff,George W. Sledge,William C. Wood,Nancy E. Davidson +10 more
TL;DR: In this paper, the efficacy of two different taxanes, docetaxel and paclitaxel, given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer was compared.
Journal ArticleDOI
Fertility Preservation in Breast Cancer Patients: A Prospective Controlled Comparison of Ovarian Stimulation With Tamoxifen and Letrozole for Embryo Cryopreservation
TL;DR: The combination of low-dose FSH with tamoxifen (TamFSH-IVF) or letrozole (Letrozoles- IVF) results in higher embryo yield compared with Tam-IVf, and the letroZole protocol may be preferred because it results in lower peak E2 levels.
Journal Article
Delayed childbearing: more women are having their first child later in life
T J Matthews,Brady E Hamilton +1 more
TL;DR: The age of the mother plays a strong role in a wide range of birth outcomes (e.g., birthweight, multiple births, and birth defects), so it is critical to track the average age at which women have their first birth.
Journal ArticleDOI
Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.
TL;DR: The diagnosis of most cancer types during pregnancy or lactation does not increase the risk of cause-specific death, and the "healthy mother effect" for women with a postcancer pregnancy is confirmed.
Journal ArticleDOI
Safety of Fertility Preservation by Ovarian Stimulation With Letrozole and Gonadotropins in Patients With Breast Cancer: A Prospective Controlled Study
TL;DR: Ovarian stimulation with gonadotropins and letrozole for the purpose of fertility preservation is unlikely to cause substantially increased recurrence risk, and longer-term follow-up is needed to confirm these findings.
Related Papers (5)
Cancer and fertility preservation: international recommendations from an expert meeting
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
Halle C. F. Moore,Joseph M. Unger,Kelly-Anne Phillips,Frances M. Boyle,Frances M. Boyle,Erika Hitre,David L. Porter,Prudence A. Francis,Lori J. Goldstein,Henry L. Gomez,Carlos S. Vallejos,Ann H. Partridge,Shaker R. Dakhil,Agustin A. Garcia,Julie R. Gralow,Janine M. Lombard,John F. Forbes,Silvana Martino,William E. Barlow,Carol J. Fabian,Lori M. Minasian,Frank L. Meyskens,Richard D. Gelber,Gabriel N. Hortobagyi,Kathy S. Albain +24 more